iA Global Asset Management Inc. Purchases New Stake in Align Technology, Inc. $ALGN

iA Global Asset Management Inc. purchased a new stake in Align Technology, Inc. (NASDAQ:ALGN) during the second quarter, HoldingsChannel reports. The firm purchased 6,066 shares of the medical equipment provider’s stock, valued at approximately $1,148,000.

A number of other large investors have also added to or reduced their stakes in the business. Tredje AP fonden raised its stake in Align Technology by 13.9% in the 2nd quarter. Tredje AP fonden now owns 131,232 shares of the medical equipment provider’s stock valued at $24,846,000 after acquiring an additional 16,034 shares during the period. Cambiar Investors LLC bought a new stake in Align Technology in the 2nd quarter valued at $10,032,000. Plato Investment Management Ltd raised its stake in Align Technology by 88.0% in the 2nd quarter. Plato Investment Management Ltd now owns 5,357 shares of the medical equipment provider’s stock valued at $1,011,000 after acquiring an additional 2,507 shares during the period. Geneva Capital Management LLC raised its stake in Align Technology by 5.6% in the 2nd quarter. Geneva Capital Management LLC now owns 31,210 shares of the medical equipment provider’s stock valued at $5,909,000 after acquiring an additional 1,654 shares during the period. Finally, Center for Financial Planning Inc. raised its stake in Align Technology by 133.5% in the 2nd quarter. Center for Financial Planning Inc. now owns 516 shares of the medical equipment provider’s stock valued at $98,000 after acquiring an additional 295 shares during the period. Institutional investors own 88.43% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on ALGN. HSBC increased their price target on Align Technology from $140.00 to $150.00 in a research note on Friday. Weiss Ratings cut Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, October 8th. Piper Sandler reiterated an “overweight” rating and set a $200.00 price objective (up previously from $190.00) on shares of Align Technology in a research report on Thursday, October 30th. Stifel Nicolaus set a $200.00 price objective on Align Technology in a research report on Thursday. Finally, Wells Fargo & Company lowered their price objective on Align Technology from $199.00 to $181.00 and set an “overweight” rating on the stock in a research report on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $175.45.

Align Technology Stock Performance

ALGN opened at $138.53 on Tuesday. The firm has a market cap of $10.04 billion, a P/E ratio of 26.85, a price-to-earnings-growth ratio of 1.49 and a beta of 1.70. Align Technology, Inc. has a 52-week low of $122.00 and a 52-week high of $246.19. The business’s fifty day moving average is $133.11 and its 200-day moving average is $161.52.

Align Technology (NASDAQ:ALGN) last released its earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.23. The company had revenue of $995.69 million for the quarter, compared to analyst estimates of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.Align Technology’s quarterly revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the firm posted $2.35 EPS. Align Technology has set its Q4 2025 guidance at EPS. On average, research analysts predict that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its board has initiated a stock repurchase program on Tuesday, August 5th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board believes its stock is undervalued.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.